Analysis on prognostic value of RS as to distant metastases in early hormone receptor positive breast cancer has been the subject of several further clinical studies since the NSABP B14 trial chemotherapy [6], [7], [8], [9], [10], [11], [12], [17]. This evidence concerns the gene NR4A1 and breast cancer.